MX2019007301A - Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida. - Google Patents

Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida.

Info

Publication number
MX2019007301A
MX2019007301A MX2019007301A MX2019007301A MX2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A
Authority
MX
Mexico
Prior art keywords
compositions
methods
pharmaceutical compounds
making substituted
substituted porphyrin
Prior art date
Application number
MX2019007301A
Other languages
English (en)
Spanish (es)
Inventor
Batinic-Haberle Ines
Tovmasyan Artak
Rajic Dzolic Zrinka
Spasojevic Ivan
Allen Lee Christopher
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of MX2019007301A publication Critical patent/MX2019007301A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B47/00—Formation or introduction of functional groups not provided for in groups C07B39/00 - C07B45/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
MX2019007301A 2016-12-20 2017-12-19 Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida. MX2019007301A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662436743P 2016-12-20 2016-12-20
PCT/US2017/067263 WO2018118891A1 (en) 2016-12-20 2017-12-19 Methods of making substituted porphyrin pharmaceutical compounds and compositions

Publications (1)

Publication Number Publication Date
MX2019007301A true MX2019007301A (es) 2019-10-30

Family

ID=62628012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007301A MX2019007301A (es) 2016-12-20 2017-12-19 Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida.

Country Status (8)

Country Link
US (1) US20190330220A1 (enExample)
EP (1) EP3558902A4 (enExample)
JP (1) JP2020502280A (enExample)
KR (1) KR20190098211A (enExample)
CN (1) CN110291060A (enExample)
CA (1) CA3046357A1 (enExample)
MX (1) MX2019007301A (enExample)
WO (1) WO2018118891A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110621377A (zh) * 2017-04-04 2019-12-27 贝奥密美体合资有限公司 治疗和/或预防与放射和/或化疗暴露有关的副作用的方法、组合物以及试剂盒
CN111417400B (zh) * 2017-09-29 2022-12-02 杜克大学 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
ATE312103T1 (de) * 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
WO2003103680A1 (en) * 2002-06-07 2003-12-18 Duke University Substituted porphyrins
WO2005077269A1 (en) * 2004-02-09 2005-08-25 Duke University Substituted porphyrins
US20110275606A1 (en) * 2009-01-07 2011-11-10 Duke University Substituted porphyrins
WO2010138633A1 (en) * 2009-05-26 2010-12-02 Duke University Method of providing neuroprotection using substituted porphyrins
WO2015112586A1 (en) * 2014-01-22 2015-07-30 Duke University Methods of treating pruritus

Also Published As

Publication number Publication date
JP2020502280A (ja) 2020-01-23
US20190330220A1 (en) 2019-10-31
EP3558902A1 (en) 2019-10-30
KR20190098211A (ko) 2019-08-21
CN110291060A (zh) 2019-09-27
WO2018118891A1 (en) 2018-06-28
EP3558902A4 (en) 2020-06-24
CA3046357A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
AR125320A2 (es) Compuesto cristalino, método de preparación y composición que lo comprende
MX2021002978A (es) Lactamas biciclicas y metodos de uso de las mismas.
PH12021553018A1 (en) New egfr inhibitors
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
EA201591497A1 (ru) Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина
EA201691439A1 (ru) Пиримидинилоксибензольные производные в качестве гербицидов
PH12015500263A1 (en) New bicyclic derivatives
EA201890522A1 (ru) Способ получения противогрибковых соединений
WO2008112939A3 (en) Composition and method for making oligo-benzamide compounds
MY187449A (en) New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl
EA201792433A1 (ru) Производные 2-(фенилокси- или фенилтио)пиримидина в качестве гербицидов
CL2020001589A1 (es) Proceso para la preparación de derivados de quinolina.
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
WO2011132051A3 (en) Tricycle compounds as phosphodiesterase-10 inhibitors
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos
CR20220004A (es) Nuevos compuestos heterocíclicos
MX2020002449A (es) Nuevos compuestos heterociclicos fungicidas.
MX2018001517A (es) Derivados sustituidos de guanidina.
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
PH12019500822B1 (en) Crystalline forms of eravacycline
WO2017064627A3 (en) Process for preparation of eribulin and intermediates thereof
CR20200267A (es) Polimorfos
WO2018039077A8 (en) Therapeutic compounds
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
MX2020006370A (es) Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas.